Testing With FullTerm™, The Fetal Fibronectin Test
The FDA has approved FullTerm™, The Fetal Fibronectin Test, for use as an aid in assessing the risk for preterm birth in women with or without symptoms of preterm labor.
IN THIS SECTION
An easy, 4-step procedure for collecting specimens, including instructions for ensuring accurate patient results.
Essential reimbursement codes associated with FullTerm, The Fetal Fibronectin Test.
Information for laboratory technicians, including step-by-step instructions for using the TLiIQ® System to provide test results to physicians.
Product information for fetal fibronectin enzyme immunoassay and Rapid fFN for the TLiIQ® System.
You will need Adobe® Acrobat® Reader.